x

Search for a clinical trial

* (*) mandatory field

Phase II pharmacokinetic study to assess the age-dependency in the clearance of Doxorubicin in paediatric patients with Solid Tumours and Leukaemia - UK

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : European
  • Sponsor : UniversitÄtsklinikum mÜnster
  • Website
    • Phase : II
  • Principal investigator of clinical trial

  • Pr Alan BODDY
  • Northern Institute for Cancer Research
  • Northern Institute for Cancer Research, Medical School, Newcastle University
  • Paul O'Gorman Building, Framlington Place
  • NEWCASTLE UPON TYNE NE2 4HH
  • UNITED KINGDOM
  • More information
  • Phone  : 44 (0)191 246 4300
  • Fax  : 44 (0)191 246 4301
  • Website
  • Contact secretary  :
Last update: June 2017

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.